Mannatech remains active at Mannatech.com as a publicly traded MLM/network-marketing company. Its common stock trades on Nasdaq under the symbol MTEX, although the company disclosed a Nasdaq continued-listing deficiency in April 2026 related to negative stockholders' equity.
Mannatech, Incorporated was incorporated in Texas on November 4, 1993, and built its business around nutritional supplements, glyconutrient products, weight-management products, skin care, anti-aging products, and related wellness offerings. The company became best known for its Ambrotose line, which is based on plant-derived polysaccharides and the company's glyconutrient positioning.
Mannatech remains active as a global direct-selling company headquartered in Flower Mound, Texas. Its current product categories include integrative health, targeted health, weight and fitness, skin care, and essentials. In its 2025 Form 10-K, the company reported approximately 114,000 active associate and preferred-customer positions, down from 133,000 in 2024. Its compensation plan includes 19 achievement levels, from Associate through Crown Platinum Ambassador, and pays commissions and incentives based on direct and indirect product sales, downline volume, and rank qualifications. Mannatech reported 2025 net sales of $108.0 million, down from $117.9 million in 2024, and a 2025 net loss of $15.2 million.
Mannatech remains publicly traded, but its current public-company status includes financial pressure. On April 20, 2026, the company received a Nasdaq notice stating that it was not in compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement. Mannatech reported a stockholders' equity deficit of $5.223 million as of December 31, 2025, leaving it approximately $7.7 million short of the requirement. The notice did not immediately delist the stock, and the company said it intended to submit a compliance plan.
between October 2022 and September 2024 involving Ambrotose Life and Ambrotose Complex products and their manufacturer, Natural Aloe de Costa Rica; Mannatech said those products and the manufacturer were released from the import alerts in 2024.
Mannatech's regulatory history includes a major Texas Attorney General case over sales practices and health-related product claims. The case was filed in July 2007 and settled in February 2009 for $6 million, including $4 million in consumer restitution and $2 million for state fees and expenses. Founder Sam Caster separately agreed to pay a $1 million fine. Mannatech's legal history also includes an $11.25 million securities class-action settlement in Jonathan Crowell v. Mannatech, Inc., covering purchasers of Mannatech stock from August 10, 2004 through July 30, 2007.
Mannatech's FDA history includes a November 14, 2017 warning letter citing dietary-supplement manufacturing violations, unapproved new-drug claims, and misbranding issues involving several products. FDA later issued a January 3, 2020 closeout letter stating that Mannatech appeared to have addressed the violations. The company also disclosed FDA import-alert issues